MIMETAS Participates in €325 Million Oncode-PACT Initiative to Accelerate and Improve Oncology Drug
LEIDEN, The Netherlands, April 19, 2022 / B3C newswire / -- MIMETAS, a global leader in organ-on-chip-based disease models, is a partner in the Oncode-PACT (Preclinical Accelerator for Cancer Treatments) initiative that has been granted today an amount of €325 million by the Dutch National Growth Fund. Oncode Instit...
United States Jos Joore Dutch Research Council Ministry Of Health Ministry Of Economic Affairs Drug Development
Source: pharmiweb.com